SAN DIEGO, October 1, 2024 – Coastar Therapeutics Inc., a biotechnology company developing novel delivery technologies to supercharge cell and gene therapies, announced that it has joined JLABS, an early stage biotech accelerator program of Johnson & Johnson Innovation. 

“We are excited to be part of JLABS, where biotech innovations are thriving.” said Eddie Y. Chung, CEO of Coastar Therapeutics, “JLABS has all the key elements of success that Coastar needs. Not only can we utilize their state-of-the-art and cost-efficient lab resources, but we can also tap into the profound expertise, community, industry connections in the J&J ecosystem.“

“I am thrilled that we are joining JLABS to accelerate our development,” said Han L. Lim, Ph.D., Coastar’s Chief Science Officer, “As an early stage startup, we will be absolutely benefiting from the abundant resources that we can access in order to advance our science. It is also exciting to be closer to our industry colleagues and potential collaborators in the J&J network.“

“JLABS is a perfect environment for innovators like us,” said Chongyang Luo, Ph.D., Coastar’s COO, “We will be much better positioned to move quickly to advance our pipeline R&D, towards our goal of breaking the bottleneck and supercharging cell and gene therapy“

For more information about Coastar Therapeutics and its mission, visit coastartherapeutics.com.

ABOUT COASTAR THERAPEUTICS

Coastar Therapeutics Inc., is a San Diego based company developing biological payload delivery technologies for cancer and gene therapies. The company’s proprietary ENHEnS^TM  and eLNPTM technology can coat cell membranes on biological payloads to help them evade recognition and clearance by the immune system and be successfully targeted to tumor or other disease sites. The company is working with a number of global partners to develop next generation therapies.

ABOUT JLABS

JLABS, a division of Johnson & Johnson Innovation, is a global life science incubator that supports early-stage companies in the development of transformative healthcare solutions. With state-of-the-art facilities, funding opportunities, and mentorship from industry experts, JLABS provides emerging biotech, pharmaceutical, medical device, and consumer health startups with the resources they need to accelerate innovation. By fostering collaboration and providing a capital-efficient, no-strings-attached model, JLABS enables entrepreneurs to advance breakthrough discoveries that have the potential to improve human health worldwide.